This approval marks the first time Smith & Nephew’s technology will be available in the world’s second largest orthopaedic market. The Genesis II knee system will be the first implant system available in Japan with Oxinium.
Smith & Nephew is said to be the only orthopaedic company to offer an award winning joint replacement material. Oxinium is a proprietary transformed metal alloy with a ceramic bearing surface that provides low friction and wear resistance combined with the strength of a metal implant.
Joseph DeVivo, president of Smith & Nephew Orthopedic Reconstruction, said: “Oxinium material has proven to be a superior metal in implants, and our technology has given patients the significant benefit of greater durability from their implants.”